Alpha GPC Injection

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of alpha gpc injection in China. Welcome to wholesale bulk high quality alpha gpc injection for sale here from our factory. Good service and reasonable price are available.

Alpha GPC Injection is an injectable pharmaceutical formulation with alpha‑glycerophosphocholine (Alpha GPC) as its primary active ingredient. As a highly bioavailable precursor of choline, this injectable preparation is primarily indicated for the enhancement of neurological function, the promotion of cognitive recovery, and the protection of neuronal cells through direct and efficient supplementation of choline in the central nervous system.

In a double‑blind, placebo‑controlled clinical trial involving 32 healthy human subjects, participants who received continuous oral administration of Alpha GPC for 10 consecutive days exhibited significantly milder deficits in attention, learning, and memory functions compared with the placebo group on the 11th day following administration of scopolamine, a pharmacological agent known to induce cognitive impairment. This study provided robust experimental evidence supporting the neuroprotective and cognitive‑enhancing effects of Alpha GPC against central cholinergic dysfunction.

Further clinical investigations have demonstrated that 1200 mg of Alpha GPC per day, administered in three divided doses of 400 mg each, can significantly improve multiple domains of cognitive function in patients diagnosed with Alzheimer's disease and other forms of dementia, including memory consolidation, executive function, attention, and daily living abilities.

Compared with oral formulations, the injectable dosage form offers distinct advantages in terms of rapid onset of action and complete bioavailability, as it avoids gastrointestinal absorption barriers and hepatic first‑pass metabolism. Therefore, injectable Alpha GPC is especially suitable for clinical scenarios requiring prompt neuroprotective and cognitive‑enhancing effects, such as postoperative cognitive recovery, acute neurological support, and intensive care interventions. In contrast, oral formulations are generally preferred for long‑term maintenance therapy, chronic neurodegenerative conditions, and daily nutritional or adjuvant pharmacological supplementation due to their convenience, ease of administration, and suitability for prolonged use.

Additional information of chemical compound:

Alpha GPC  COA

Alpha GPC injection, as an efficient choline supplement, is widely used in the fields of cognitive enhancement, neural repair, and motor performance optimization due to its ability to penetrate the blood-brain barrier and increase acetylcholine levels. The choice of dosage form directly affects the absorption, distribution, metabolism, and excretion of drugs in the body, thereby determining their efficacy and safety. There are significant differences between injectable and oral formulations as the two mainstream forms in terms of bioavailability, onset speed, duration of action, and clinical application scenarios.

Bioavailability refers to the speed and degree at which drugs enter the systemic circulation, and is a core indicator for evaluating drug absorption efficiency. According to different administration routes, bioavailability can be divided into absolute bioavailability and relative bioavailability: the former refers to the proportion of drugs that enter the systemic circulation 100% during intravenous injection, while the latter compares the absorption efficiency of other administration routes with intravenous injection as a reference.

The key factors affecting bioavailability include:

Physical and chemical properties of drugs

Molecular weight, lipid solubility, water solubility, and dissociation degree directly affect the transmembrane transport ability of drugs.

Formulation design

The injectable form directly enters the bloodstream, bypassing the first pass effect; Oral dosage forms require dissolution and absorption through the gastrointestinal tract and may be affected by liver enzyme metabolism.

The bioavailability characteristics of Alpha GPC injection form

Pharmacokinetic advantages:

The injectable form delivers drugs directly to the systemic circulation through intravenous or intramuscular injection, completely bypassing gastrointestinal absorption and hepatic first pass metabolism, and has the following advantages:

Rapid onset of action: The drug reaches its peak concentration (Cmax) immediately after intravenous injection, and takes effect within about 30 minutes after intramuscular injection. It is suitable for emergency intervention in acute nerve injury or cognitive crisis.

The bioavailability is close to 100%: Due to the absence of absorption, the absolute bioavailability of injectable formulations is theoretically 100%, while oral formulations typically have a bioavailability of less than 50% due to first pass effects and gastrointestinal degradation.
Stable blood drug concentration: Through controlled release technology or continuous intravenous infusion, a constant blood drug concentration can be maintained, reducing the impact of fluctuations on efficacy.

Clinical Application Scenarios

Acute brain injury treatment: In the acute phase of stroke or traumatic brain injury (TBI), injectable forms can rapidly increase choline levels in the brain and promote nerve repair. For example, a multicenter clinical trial in Italy showed that patients with acute stroke who received 1000mg/day Alpha GPC injection for 28 days, followed by oral administration of 400mg/day for 5 months, had significantly better cognitive recovery scores than the group receiving oral administration alone.
Status epilepticus: Animal experiments have shown that injecting 250mg/kg Alpha GPC within 3 weeks after epileptic seizures can improve cognitive impairment and increase acetylcholine release in the hippocampus, with better effects than oral formulations.

Intensive care scenario: For patients who are unable to receive oral medication (such as postoperative coma or mechanically ventilated patients), the injectable form is the only feasible administration method.

Safety and Limitations

Local stimulation: Muscle injection may cause pain or hardening, and the risk needs to be reduced by optimizing the solvent formula (such as diluting with physiological saline).
Allergic reactions: A very small number of patients may experience allergic reactions, and it is necessary to strictly follow the indications and prepare emergency measures.
Cost and convenience: The injectable form requires professional medical personnel to operate, and the storage conditions are harsh (such as avoiding light and low temperature), which limits its application in outpatient and home settings.

Absorption and Metabolic Mechanisms

 

Oral administration of Alpha GPC requires dissolution and absorption through the gastrointestinal tract, and may be affected by first pass effects. Its bioavailability is constrained by the following factors:

Formulation design: Capsule formulation improves absorption efficiency by protecting the drug from gastric acid damage; However, regular tablets may experience slower absorption due to delayed disintegration.
Food interaction: A high-fat diet may indirectly affect the dissolution and absorption of Alpha GPC by delaying gastric emptying or stimulating bile secretion.

First pass metabolism: Some drugs are metabolized into inactive products in the liver, leading to a decrease in bioavailability. For example, the bioavailability of some oral choline supplements is less than 20%, while Alpha GPC has a low first pass metabolic rate due to its structural specificity, with a bioavailability of up to 40% -60%. 

Sports nutrition supplement: Alpha GPC is widely used for optimizing sports performance by increasing growth hormone secretion and promoting muscle contraction. Research shows that taking 600mg Alpha GPC 90 minutes before resistance training can increase peak growth hormone levels by 44 times and bench press strength by 14%.

Clinical Application Scenarios

 

Chronic neurodegenerative diseases: For chronic diseases such as Alzheimer's disease and vascular dementia, oral formulations have become the preferred choice due to their convenience. Long term clinical trials have shown that taking 1200mg daily (divided into three doses) can significantly improve cognitive function and has good tolerability.
Cognitive enhancement in healthy individuals: Athletes, students, and other healthy individuals can improve their attention, memory, and athletic performance through oral administration of Alpha GPC. For example, a study involving young healthy adults found that 400mg Alpha GPC can improve continuous subtraction test scores by 18%, and the neuroallergy score is significantly lower than that of the caffeine group.

Strategies for optimizing oral bioavailability

 

Formulation improvement: Adopting nanocrystal technology or liposome encapsulation to enhance drug solubility and transmembrane transport capability. For example, the bioavailability of nano Alpha GPC is 30% higher than that of traditional formulations.
Adjustment of administration time: Taking on an empty stomach can reduce food interference, but may cause gastrointestinal discomfort; If taken after meals, the dosing interval should be extended to avoid delayed absorption.

Comparison of bioavailability and therapeutic efficacy

Intramuscular injection (IM) promotes drug absorption by injecting drugs into muscle tissue, utilizing the rich blood flow and capillary network of muscles. Its pharmacokinetic characteristics are as follows: 

Pharmacokinetic characteristics

 

Moderate absorption rate: After intramuscular injection, the drug needs to be absorbed into the bloodstream through capillaries, usually taking effect within 30 minutes, but the absorption rate is slower than intravenous injection.
High bioavailability: The bioavailability of intramuscular injection can reach 80% -90%, significantly higher than oral dosage forms but lower than intravenous injection.Small fluctuations in blood drug concentration: After intramuscular injection, drug release is slower, and blood drug concentration fluctuations are smaller than intravenous injection, making it suitable for scenarios that require long-term maintenance of drug efficacy.

Clinical application scenarios

 

Chronic neurodegenerative diseases: For chronic diseases such as Alzheimer's disease and vascular dementia, intramuscular injection of Alpha GPC can maintain long-term levels of choline in the brain and improve cognitive function. For example, a 180 day double-blind randomized placebo-controlled trial showed that daily intramuscular injection of 400mg Alpha GPC significantly improved cognitive scores in Alzheimer's disease patients.
Sports nutrition supplement: Athletes can improve their athletic performance by injecting Alpha GPC into their muscles. Research has shown that intramuscular injection of 600mg Alpha GPC 90 minutes before resistance training can increase peak levels of growth hormone by 44 times and bench press strength by 14%.
Outpatient treatment: Muscle injection is easy to operate, does not require continuous monitoring, and is suitable for outpatient patients or home care scenarios.

Safety and Limitations

 

Local pain and induration: Muscle injection may cause pain or induration at the injection site, and the risk needs to be reduced by optimizing injection techniques (such as rotating injection sites).
Absorption delay: In the case of low temperature or reduced blood flow, the absorption rate of intramuscular injection may slow down, affecting the efficacy.
Dose limitation: The single dose of intramuscular injection usually does not exceed 5mL, which limits the administration of high-dose drugs.

Pharmacokinetic characteristics

 

Intrathecal injection (IT) achieves high concentration distribution of drugs in the central nervous system (CNS) by directly injecting drugs into cerebrospinal fluid (CSF), bypassing the blood-brain barrier. Its pharmacokinetic characteristics are as follows:

Directly entering the CNS: After intrathecal injection, the drug quickly distributes to the cerebrospinal fluid without the need for blood circulation, thus rapidly increasing the concentration of drugs in the brain. For example, after intrathecal injection of Alpha GPC, the drug concentration in cerebrospinal fluid can reach its peak within 0.25 hours (Tmax=0.25h), while the drug concentration in plasma takes 4 hours to reach its peak (Tmax=4h).

Long half-life: Alpha GPC has an elimination half-life of 139 ± 54 days in CNS tissues, significantly longer than its half-life in plasma (usually several hours), thus reducing dosing frequency and improving patient compliance.
Concentration gradient distribution: The drug is distributed in a concentration gradient around the lumbar spine and towards the tip of the head in CNS tissue, with the highest concentration in the lumbar spine and the lowest concentration in the cerebral cortex.

Clinical Application Scenarios

 

Central nervous system diseases: Intrathecal injection of Alpha GPC is suitable for treating central nervous system diseases such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). For example, Nusirersen (an intrathecal injection of antisense oligonucleotide drug) can significantly improve patients' motor function through intrathecal injection therapy for SMA.
Neuroprotection and Repair: Intrathecal injection of Alpha GPC can promote nerve repair and improve cognitive function after epilepsy, stroke, or brain injury. Animal experiments have shown that intrathecal injection of Alpha GPC after epileptic seizures can increase neurogenesis in the hippocampus and improve cognitive impairment.
Intractable pain: Intrathecal injection of Alpha GPC can alleviate refractory neuropathic pain by regulating neurotransmitter release.

Safety and Limitations

 

Operational risk: Intrathecal injection must be carried out under strict sterile conditions, improper operation may cause cerebrospinal fluid leakage, infection, or nerve damage.
Uneven distribution of drugs: The concentration gradient distribution of drugs in CNS tissues may lead to uneven therapeutic effects, and the risk needs to be reduced by optimizing the dosage and frequency of administration.
Long term safety unknown: Due to the short clinical application time of intrathecal injection of Alpha GPC, its long-term safety (such as neurotoxicity and immunogenicity) still needs further research.

Comparison of pharmacokinetic parameters

Hot Tags: alpha gpc injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale